Elizabeth Nielson PhD
AUTHOR

Elizabeth Nielson PhD

Health & Wellness
Tap the gear icon above to manage new release emails.
Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder, and has served as a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, psilocybin-assisted treatment of treatment resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted psychotherapy. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy. "Our mission is to educate the broader health care community about psychedelic science and equip practitioners with relevant clinical skills."
Read more Read less

Try Audible membership today. Start enjoying the benefits.

Try Audible for free with an audiobook of your choice.
Try Premium Plus free
Automatically renews at AUD $16.45/mo after 30 days. Cancel anytime.

Most Popular

Product list
  • The Psychedelic Therapy Workbook cover art

    Non-member price: $12.99 or 1 Credit

    Sale price: $12.99 or 1 Credit

    Try for $0.00